Axitinib multi target TKI

AG-013736 - AG013736 - AG 013736 - Inlyta      

pdf
pathology Demonstrated benefit and harm k      
renal-cell carcinoma (advanced)

versus

No demonstrated result for efficacy

2 trialsmeta-analysis